Explant date was confirmed as (b)(6) 2019.According to the reported information, the patient presented 5 weeks later, therefore the estimated date of event will be (b)(6) 2019.The explanted device is not being returned to gore for analysis.However the histological analysis from the hospital is attached.According to the gore® seamguard® bioabsorbable staple line reinforcement instructions for use (ifu), adverse events that may occur and/or require intervention include, but are not limited to: infection, inflammation, adhesions and hematoma.
|
It was reported that a patient underwent a gastric sleeve procedure using gore® seamguard® bioabsorbable staple line reinforcement.It was reported the seamguard was adherent to the diaphragm, pancreas and omentum, which required extensive dissection to free and unkink the sleeve.Theatre laparoscopy with dense adhesions and inflammation along the staple line were noted.It was reported it felt rock hard along the entire length of where the seamguard was implanted.Endoscopy showed some mid body angulation and it was reported the patient was unable to tolerate a barium swallow.It was reported to gore that after 5 weeks the patient came in reporting complete intolerance for liquids and solids.The patient reported nausea immediately post operatively.It was reported the patient has gone home and is doing well, however will need additional scopes and treatment.
|